As of Apr 29
| +0.02 / +0.06%|
The 2 analysts offering 12-month price forecasts for Medifast Inc have a median target of 33.50, with a high estimate of 35.00 and a low estimate of 32.00. The median estimate represents a +6.25% increase from the last price of 31.53.
The current consensus among 2 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.